PFE | Financial Buzz

Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Begins Human Trial Testing Oral Drug Against Covid-19

Rebecca Urena03/23/202103/23/2021

1937

Pfizer (NYSE: PFE) announced Tuesday that it has commenced the clinical trial for an experimental oral antiviral Covid-19 drug. The pill is expected to be used at the first...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

Bryan Shin03/11/2021

3880

Pfizer Inc. (NYSE: PFE), The Israel Ministry of Health and BioNTech SE (NASDAQ: BNTX) reported evidence that demonstrates lower incidence rates of COVID-19 disease in individuals that are vaccinated...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Myovant Sciences Stock Rises After Pfizer Collaboration

Danny Abramov12/28/2020

3827

Myovant Sciences Ltd. (NYSE: MYOV) stock jumped more than 26% after the clinical-stage biopharmaceutical company announced a collaboration with Pfizer Inc. (NYSE: PFE) to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH)...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

The U.K. Approves Pfizer’s Covid Vaccine

Rebecca Urena12/03/2020

1646

Wednesday, the U.K. became the first country to approve Pfizer’s (NYSE: PFE) coronavirus vaccine for emergency use, and will begin administering shots in just a few days. The move...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech Report that Phase 3 Study of COVID-19 Vaccine Candidate Meets All Primary Efficacy Endpoints

Danny Abramov11/18/202011/18/2020

16388

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) made another announcement regarding their vaccine candidate. After conducting the final efficacy analysis in their ongoing Phase 3 study, their...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech SE Announce that COVID-19 Vaccine Candidate is 90% Effective

Danny Abramov11/09/202011/09/2020

9310

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced major news on Monday regarding their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2. The vaccine candidate has demonstrated evidence of efficacy against COVID-19...

Tag: PFE